Travere Therapeutics Inc
Ownership
Ownership Structure
Who owns Travere Therapeutics Inc (TVTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.8% of the shares are freely tradable; institutional investors hold 113.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| HHG PLC | 12.11 | 11,419,586 | +8.6 | 03/31/2026 |
| FMR Inc | 11.64 | 10,967,967 | +14.0 | 03/31/2026 |
| BlackRock Inc | 8.27 | 7,792,033 | -1.0 | 03/31/2026 |
| State Street Corp | 5.26 | 4,959,988 | +4.3 | 03/31/2026 |
| Armistice Capital, LLC | 5.20 | 4,897,417 | +30.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.29 | 4,045,812 | +0.0 | 03/31/2026 |
| Perceptive Advisors LLC | 3.98 | 3,752,574 | -9.4 | 06/30/2026 |
| Delaware Management Holdings Inc | 3.47 | 3,270,513 | -13.3 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 2.73 | 2,569,356 | +163.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.14 | 2,958,087 | +0.3 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 118,016 | 7,635,635 $ | Sep 2, 2026 | direct |
| Meckler Jeffrey A | Director | 91,500 | 5,920,050 $ | Sep 10, 2026 | direct |
| Lyons Gary A | Director | 61,500 | 3,979,050 $ | Aug 18, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Meckler Jeffrey A | Director | Sell | 3,100 | 68.09 | 211,073 |
| Sep 10, 2026 | Meckler Jeffrey A | Director | Sell | 14,000 | 67.46 | 944,488 |
| Sep 10, 2026 | Meckler Jeffrey A | Director | Sell | 1,200 | 66.15 | 79,380 |
| Sep 10, 2026 | Meckler Jeffrey A | Director | Sell | 1,700 | 65.39 | 111,166 |
| Sep 10, 2026 | Meckler Jeffrey A | Director | Other | 10,000 | 26.52 | 265,200 |
| Sep 2, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 642 | 66.37 | 42,610 |
| Aug 18, 2026 | Lyons Gary A | Director | Sell | 900 | 63.86 | 57,470 |
| Aug 18, 2026 | Lyons Gary A | Director | Sell | 4,100 | 63.27 | 259,390 |
| Aug 18, 2026 | Lyons Gary A | Director | Other | 5,000 | 17.44 | 87,200 |
| Aug 17, 2026 | Lyons Gary A | Director | Sell | 500 | 64.16 | 32,081 |
| Aug 17, 2026 | Lyons Gary A | Director | Sell | 2,600 | 63.50 | 165,100 |
| Aug 17, 2026 | Lyons Gary A | Director | Sell | 1,900 | 62.53 | 118,805 |
| Aug 17, 2026 | Lyons Gary A | Director | Other | 5,000 | 17.44 | 87,200 |
| Apr 22, 2026 | William E Rote | Insider | Sell | 9,100 | 39.09 | 355,719 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.